DGAP-Adhoc 562 0 Kommentare MeVis Medical Solutions AG: Contrary to expectations, in 2014 no increase in resources necessary / In the mid-term new business model with customer Hologic envisaged

MeVis Medical Solutions AG / Key word(s): Miscellaneous

17.01.2014 17:57

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Bremen, January 17, 2014 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4],
a leading provider of medical imaging software, announces that its biggest
customer Hologic, Inc. aims for an altered form of cooperation with MeVis
in the mid-term.

Over a transition period of several years the licensing business model
shall be converted to development support for Hologic starting probably
2016. MeVis will continue to contribute its clinical know-how and software
development expertise in the development of applications as a strategic
partner. As a result, MeVis expects in the mid- and long-term a gradual
reduction of necessary resources for the Hologic business and the expected
revenues. The specific terms of the future cooperation and its contractual
implementation will be elaborated in the coming months.

Accordingly the Executive Board has decided - unlike announced on November
4, 2013 - not to increase resources for Hologic for the time being.

A forecast for the financial year 2014 will be published with the annual
report in April 2014 at the latest.

17.01.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------

Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: ir@mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, München, Stuttgart

End of Announcement DGAP News-Service

---------------------------------------------------------------------------